Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Short Interest Down 67.5% in December

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) was the target of a large drop in short interest in the month of December. As of December 31st, there was short interest totalling 478,400 shares, a drop of 67.5% from the December 15th total of 1,470,000 shares. Approximately 6.1% of the company’s shares are short sold. Based on an average trading volume of 1,770,000 shares, the short-interest ratio is presently 0.3 days.

Cumberland Pharmaceuticals Stock Up 16.7 %

Cumberland Pharmaceuticals stock traded up $0.39 during midday trading on Tuesday, hitting $2.72. 7,294,746 shares of the stock were exchanged, compared to its average volume of 872,232. Cumberland Pharmaceuticals has a 1 year low of $1.04 and a 1 year high of $3.93. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.13 and a quick ratio of 0.99. The firm has a market cap of $38.19 million, a P/E ratio of -3.53 and a beta of 0.13. The company has a 50 day moving average price of $1.76 and a two-hundred day moving average price of $1.49.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Cumberland Pharmaceuticals in a report on Monday. They issued a “hold” rating for the company.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.